Research Topics
Species | Ronald B GoldbergSummaryAffiliation: University of Miami Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapyRonald B Goldberg
Lipid Disorders Clinic, Division of Endocrinology Diabetes and Metabolism, and Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA
Arch Intern Med 168:1531-40. 2008..Poor glycemic control is a risk factor for microvascular complications in patients with type 2 diabetes mellitus. Achieving glycemic control safely with insulin therapy can be challenging...- Effects of niacin on glucose control in patients with dyslipidemiaRonald B Goldberg
Lipid Disorders Clinic, Division of Endocrinology, Diabetes, and Metabolism, University of Miami Leonard M Miller School of Medicine, 1450 NW 10th Ave, Miami, FL 33136, USA
Mayo Clin Proc 83:470-8. 2008..Consensus guidelines recommend monitoring glycemic control after initiating niacin treatment or increasing its dosage... - Fish oil in the treatment of dyslipidemiaRonald B Goldberg
Division of Endocrinology and Metabolism, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
Curr Opin Endocrinol Diabetes Obes 15:167-74. 2008..This review examines the evidence supporting the use of omega-3 fatty acid treatment in dyslipidemic states... - Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemiaRonald B Goldberg
University of Miami Miller School of Medicine, Miami, Florida, USA
Diabetes Care 33:1021-4. 2010..To investigate relationships between baseline factors and treatment-associated efficacy changes in type 2 diabetes... - Thiazolidinediones and vascular damageRonald B Goldberg
Division of Endocrinology, Diabetes and Metabolism, Diabetes Research Institute, The University of Miami Miller School of Medicine, Miami, Florida 33136, USA
Curr Opin Endocrinol Diabetes Obes 14:108-15. 2007.... - The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled?Ronald B Goldberg
Division of Endocrinology, Diabetes and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
Curr Opin Lipidol 18:435-42. 2007..Three new controlled clinical trials of thiazolidinediones offer new information on the clinical utility of these agents... - Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL studyRonald B Goldberg
Diabetes Research Institute, Miller School of Medicine, University of Miami, 1450 NW 10th Ave, Miami, FL 33136, USA
Mayo Clin Proc 81:1579-88. 2006..To compare the efficacy and safety of the recommended usual starting and next highest doses of ezetimibe/ simvastatin and atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia... - Lifestyle interventions to prevent type 2 diabetesRonald B Goldberg
Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
Lancet 368:1634-6. 2006 - Impact of thiazolidenediones on serum lipoprotein levelsRonald B Goldberg
Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine, 1450 NW 10th Avenue, Miami, FL 33136, USA
Curr Atheroscler Rep 8:397-404. 2006..The clinical implications of these effects need further exploration... - Cardiovascular disease in patients who have diabetesRonald B Goldberg
Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Institute, University of Miami School of Medicine, 1450 NW 10th Avenue R77, Miami, FL 33136, USA
Cardiol Clin 21:399-413, vii. 2003..In addition, newer agents and early intervention in prediabetic and diabetic individuals hold promise for even greater success in the prevention of this important complication of diabetes... - Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health StudyBiing Jiun Shen
Department of Psychology, University of Miami, Coral Gables, FL 33124 0751, USA
Ann Epidemiol 16:131-7. 2006..This study uses confirmatory factor analysis to evaluate the factor structure of the MS and examines its similarity between men and women and across three ethnic groups (Caucasian, African, and Cuban Americans)... - Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and functionJohanna R Klaus
Behavioral Medicine Research Center, University of Miami, Miami, FL 33136, USA
J Cardiometab Syndr 4:63-71. 2009..The findings suggest predominant pathways through which subclinical metabolic processes may exert pathogenic impact on the heart and vasculature... - Management of dyslipidemia in diabetesMaria P Solano
University of Miami School of Medicine, Miami, Florida, USA
Cardiol Rev 14:125-35. 2006..Statin therapy is recommended for most subjects but, frequently, a combination of lipid-lowering agents is required. A number of combinations are possible, and several factors should be considered to improve the safety of this strategy... - Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetesRuth S Weinstock
Division of Endocrinology, Diabetes and Metabolism, SUNY Upstate Medical University and VA Medical Center, 750 E Adams Street, CWB 353, Syracuse, NY 13210, USA
J Clin Lipidol 2:25-35. 2008.... - Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetesJohn R Guyton
Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, Box 3510, Duke University, Durham, NC 27710, USA
J Clin Lipidol 2:19-24. 2008.... - Long-term oral contraceptive treatment, metabolic syndrome and measures of cardiovascular risk in pre-menopausal women: National Health and Nutrition Examination Survey 1999-2004Barry E Hurwitz
Behavioral Medicine Research Centre, University of Miami, Clinical Research Building 777, 1120 NW 14th Street, Miami, FL 33136, USA
Gynecol Endocrinol 25:441-9. 2009..Differences in subclinical cardiometabolic measures were examined as a function of oral contraceptive pills (OCP) treatment duration to compare never-treated women with four OCP-treatment groups (<1, 1-5, 5-10 and >10 years)... - Clinical decisions. Management of type 2 diabetesRonald B Goldberg
Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, USA
N Engl J Med 358:293-7. 2008 - Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphismToni I Pollin
Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland21201, USA
J Clin Endocrinol Metab 96:E1142-7. 2011..OBJECTIVE, SETTING, AND PATIENTS: We sought to replicate these associations and evaluate interactions with lifestyle and metformin interventions in the multiethnic Diabetes Prevention Program (DPP)... - Management of diabetic dyslipidemiaMaria Del Pilar Solano
Division of Diabetes, Endocrinology, and Metabolism, Diabetes Research Institute, University of Miami, Miami, FL 33136, USA
Endocrinol Metab Clin North Am 34:1-25, v. 2005..Although statin therapy is recommended for most subjects, judicious use of combination therapy should be considered in the highest risk subjects... - A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemiaRonald B Goldberg
Division of Endocrinology, Metabolism and Diabetes, University of Miami School of Medicine, Miami, Florida, USA
Diabetes Care 28:1547-54. 2005..Pioglitazone compared with rosiglitazone is associated with significant improvements in triglycerides, HDL cholesterol, LDL particle concentration, and LDL particle size... - Effect of behavioral interventions on insulin sensitivity and atherosclerosis in the Watanabe heritable hyperlipidemic rabbitJulie A Gonzales
Department of Psychology, University of Miami, Coral Gables, FL 33124, USA
Psychosom Med 67:172-8. 2005..Similarly, exercise training, without dietary control, does not influence the progression of disease in WHHLs... - Ability of serum to decrease cellular acylCoA:cholesterol acyl transferase activity predicts cardiovascular outcomesJulio A Chirinos
Miller School of Medicine, University of Miami, Miami, FL 33138, USA
Circulation 112:2446-53. 2005..We evaluated whether cholesterol efflux activity of serum is associated with the presence of angiographic coronary artery disease (CAD) and the risk of major adverse cardiovascular events (MACE) and death... - Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan studyTatjana Rundek
Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
Arch Neurol 67:1195-200. 2010..Whether insulin resistance predicts ischemic stroke (IS) is still a matter of debate... - Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complicationsRonald B Goldberg
Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida 33101, USA
J Clin Endocrinol Metab 94:3171-82. 2009..Their circulating biomarkers may therefore provide opportunities for early diagnosis and targets for novel treatments... - Severe acquired (secondary) high-density lipoprotein deficiencyRonald B Goldberg
Lipid Disorders Clinic, Division of Endocrinology Diabetes and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, 1450 N W 10th Avenue, Miami, FL 33136, USA
J Clin Lipidol 1:41-56. 2007..Case discussions from our clinical experience are provided to illustrate to the practitioner the clinical context in which these severe acquired deficiencies of HDL occur... - Sensory function and albumin excretion according to diagnostic criteria for diabetesJay M Sosenko
Department of Medicine, University of Miami School of Medicine, Miami, FL 33101, USA
Diabetes Care 27:1716-20. 2004..The purpose of this study was to examine sensory function and albumin excretion according to categories of glucose tolerance in individuals undergoing screening for diabetes... - Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effectsHarold E Bays
Louisville Metabolic and Atherosclerosis Research Center Inc, 3288 Illinois Ave, Louisville, KY 40213, USA
Arch Intern Med 168:1975-83. 2008..Bile acid sequestrants are a well-accepted class of cholesterol-lowering drugs. Over the last decade, small studies have indicated that these agents may also lower glucose levels in patients with type 2 diabetes mellitus (T2DM)... - Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention programAllan F Moore
Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
Diabetes 57:2503-10. 2008.... - Type 2 diabetes mellitus among Florida children and adolescents, 1994 through 1998Christine J Macaluso
University of South Florida, Tampa, FL, USA
Public Health Rep 117:373-9. 2002..This study was undertaken to examine the trends in the diagnosis of Type 2 diabetes mellitus among children and adolescents with new-onset diabetes seen from 1994 through 1998 at the three university-based diabetes centers in Florida... - Lifestyle intervention to prevent diabetes: intensive and cost effectiveJudith Wylie-Rosett
Division of Health Behavior and Nutrition, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, New York, USA
Curr Opin Lipidol 17:37-44. 2006..Although there is more to be learned about effective strategies in clinical practice, it seems clear that the intervention needs to incorporate individualization and long-term interaction with trained facilitators... - Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION studyJosefina Medina Lezama
Santa Maria Catholic University School of Medicine and Santa Maria Research Institute, Arequipa, Peru
Diabetes Res Clin Pract 78:270-81. 2007..Further studies are required to characterize genetic and environmental determinants of these patterns... - Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemiaMark A Deeg
Department of Endocrinology and Metabolism, Veterans Affairs Hospital and Indiana University, Indianapolis, Indiana, USA
Diabetes Care 30:2458-64. 2007..We studied the effects of pioglitazone (PIO) and rosiglitazone (ROSI) treatments on serum lipoprotein particle concentrations and sizes in type 2 diabetic patients with dyslipidemia... - The 'forgotten' bile acid sequestrants: is now a good time to remember?Harold E Bays
Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY 40213, USA
Am J Ther 14:567-80. 2007.... - Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randDavid C Robbins
Diabetes and Endocrine Platform Team, Eli Lilly and Company, Indianapolis, IN 46285, USA
Clin Ther 29:2349-64. 2007..Using lispro mix (LM) 50/50 before meals may be a logical approach to achieving glycemic targets (glycosylated hemoglobin [HbA(lc)] and pre- and postprandial blood glucose [BG] concentrations) in these patients... - Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology FoundationJohn D Brunzell
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, and the Northwest Lipid Laboratory, University of Washington, Seattle, Washington, USA
Diabetes Care 31:811-22. 2008 - Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology FoundationJohn D Brunzell
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, Northwest Lipid Laboratory, University of Washington, Seattle, Washington, USA
J Am Coll Cardiol 51:1512-24. 2008 - New strategies for the treatment of diabetic dyslipidemiaSteven M Haffner
Diabetes Care 25:1237-9. 2002
Research Grants
- Post Diabetes Prevention Program Follow-up StudyRonald Goldberg; Fiscal Year: 2007..women, and in older subjects in the DPP. The current application is for 5 years of funding, although the some of the goals of the projects described will require a 10-year study. ..
- Biomarkers and Outcomes in the Diabetes Prevention ProgramRonald Goldberg; Fiscal Year: 2009....
- Biomarkers and Outcomes in the Diabetes Prevention ProgramRonald B Goldberg; Fiscal Year: 2010....